Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT）
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lin Shen, M.D
Beijing Cancer Hospital, Peking University
Principal Investigator - Ruihua Xu, M.D
Cancer Center, Sun Yet-sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
- the Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
- Beijing Cancer Hospital, Peking University
Beijing, Beijing Municipality, China
- Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Chinese Academy of Medical Sciences Cancer Hospital
Beijing, Beijing Municipality, China
- Pla Hospital 301
Beijing, Beijing Municipality, China
- the Third Affiliated Hospital of the Third Military Medical University
Chongqing, Chongqing Municipality, China
- Fujian Medical University Union Hospital
Fuzhou, Fujian, China
- Cancer Center, Sun Yet-Sen University
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Guangzhou Medical University of Chinese Medicine
Guangzhou, Guangdong, China
- Cancer Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
- Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
- Hainan General Hospital
Hainan, Hainan, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- the First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
- Cancer Hospital of Henan Province
Zhengzhou, Henan, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
- Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
- Wuhan General Hospital of Guangzhou Military
Wuhan, Hubei, China
- Cancer Hospital of Hunan Province
Changsha, Hunan, China
- the Third Xiangya Hospital of Cental South University
Changsha, Hunan, China
- the First People'S Hospital of Changzhou
Changzhou, Jiangsu, China
- Cancer Hospital of Jiangsu Province
Nanjing, Jiangsu, China
- the Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
- the Affiliated Hospital of Xuzhou Medical Collage
Xuzhou, Jiangsu, China
- Cancer Hospital of Jiangxi Province
Nanchang, Jiangxi, China
- the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
- Cancer Hospital of Jilin Province
Changchun, Jilin, China
- the First Affiliated Hospital of Jilin University
Changchun, Jilin, China
- Cancer Hospital of Liaoning Province
Shenyang, Liaoning, China
- Chinese Medical University First Hospital
Shenyang, Liaoning, China
- Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
- Ruijin Hospital, Shanghai Jiaotong University, School of Medicine
Shanghai, Shanghai Municipality, China
- Shanghai General Hospital
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
- Cancer Hospital of Shanxi Province
Xian, Shanxi, China
- Tangdu Hospital of the Fouth Military Medical University
Xian, Shanxi, China
- Cancer Hospital of Tianjin City
Tianjin, Tianjin Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 28 Feb 2019
- Completion
- 31 Jul 2019
- Last update posted
- 22 Dec 2020
- Registered enrollment
- 543
- Registry id
- NCT02390947
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.